Ferm Translational Pharma Consulting AB

ABIn liquidation

Org 5569252918Research and experimental development on biotechnology · NACE 7211Est. 20130 employees

Overview Financials People & ownership Related companies

Ferm Translational Pharma Consulting AB er a Swedish AB, som opererer i Bioteknisk forskning och utveckling-sektoren. Stiftet i 2013 har 0 medarbejdere og rapporterede en omsætning på SEK 0 i seneste årsrapport.

Omsætning 2020

SEK 0

EBITDA-margin

—

+50% vs. 2019

Soliditetsgrad

97.7%

Finansiel styrke

Nettoresultat 2020

SEK -2K

+50% vs. 2019

EBITDA — year on year

SEK millions

Key figures

Annual report 2020

Revenue	SEK 0	—
EBITDA	SEK -2K	+50%
Net profit	SEK -2K	+50%
Total assets	SEK 43K	-4%
Equity	SEK 42K	-5%
Employees	0	—

Contact

Address

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Ofte stillede spørgsmål

Hvad er Org-nummeret på Ferm Translational Pharma Consulting AB?

Ferm Translational Pharma Consulting AB er registreret hos Bolagsverket / SCB under Org 5569252918.

Hvem er administrerende direktør i Ferm Translational Pharma Consulting AB?

Mats Olof Torkel Ferm er Chief Executive Officer i Ferm Translational Pharma Consulting AB, i rollen siden 2020.

Hvem er bestyrelsesformand i Ferm Translational Pharma Consulting AB?

Inger Maria Zetterström Karlsson er bestyrelsesformand i Ferm Translational Pharma Consulting AB, i rollen siden 2020.

Ferm Translational Pharma Consulting AB

EBITDA — year on year

Key figures

Company information

Contact

Ofte stillede spørgsmål

More on Ferm Translational Pharma Consulting AB

EBITDA — year on year

Key figures

Company information

Contact

Ofte stillede spørgsmål

More on Ferm Translational Pharma Consulting AB